News &
Notifications

Home 9 Newsroom ( Page 42 )

Newsroom

Here you will find the latest ESG and investor relations news, studies and press releases from cometis AG and our partner PRGN – Public Relations Global Network.
With the capital market panel and the investor relations panel, cometis has been conducting studies on current market events in the areas of capital markets, ESG and investor relations for several years. To this end, cometis surveys experts from the respective departments several times a year on current topics. In this context, cometis evaluates the topics and the concept and is also responsible for conducting the study.

 

Here, you can go directly to the respective years of Investor Relations News:

Make “Buy & Build” understandable

Make “Buy & Build” understandable

Your Contact Michael Diegelmann +49 611 20 58 55 ...
The “downfall of equity research” … opens up new opportunities for listed SMEs

The “downfall of equity research” … opens up new opportunities for listed SMEs

Your Contact Michael Diegelmann +49 611 20 58 55 ...
<span id=July 29, 2019 | Dermapharm Holding SE: Dr. Jürgen Ott named new CMO" width="172" height="174" data-ratio="1.0116279069767"/>

| Dermapharm Holding SE: Dr. Jürgen Ott named new CMO

Grünwald, July 29, 2019 – The Supervisory Board of Dermapharm Holding SE (“Dermapharm”) has announced a change in the composition of the Management Board. The current Chief Marketing Officer Stefan Grieving will be leaving the company for health reasons on July 31, 2019. Dr. Jürgen Ott to succeed him as of October 1, 2019.
Cannabis companies are welcome

Cannabis companies are welcome

Your Contact Michael Diegelmann +49 611 20 58 55 ...

CONTACT

Accept Privacy Policy

DIRECTION